Finance Watch: Investors Remain Receptive To Biopharma, Health Care SPAC IPOs
Gracell, Cullinan Launch Year’s First Offerings; Seven More Join Queue
Public Company Edition: 2020 started with two $200m-plus initial public offerings plus five health care-focused special purpose acquisition corporations IPOs. Also, a Pfizer initiative backs three public companies, Fate’s $432m offering led recent FOPOs and Biocon Biologics receives more investment.
